期刊
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
卷 162B, 期 3, 页码 245-252出版社
WILEY
DOI: 10.1002/ajmg.b.32141
关键词
catechol-O-methyltransferase; val158met; anxiety; depression; internalizing; replication
资金
- NARSAD
- CIHR
- GCRC [M01-RR10710]
- National Institute of Mental Health [R01 MH069942]
- Children's Health Research Institute
- Ontario Ministry of Research and Innovation
- Canadian Institutes of Health Research Institutes (CIHR)
- Ontario Mental Health Foundation
- Young Investigator award from NARSAD
- CIHR operating grant
- GCRC grant [M01-RR10710]
Catechol-O-Methyltransferase (COMT) is a critical regulator of catecholamine levels in the brain. A functional polymorphism of the COMT gene, val158met, has been linked to internalizing symptoms (i.e., depression and anxiety) in adolescents and adults. We extended this research by investigating whether the val158met polymorphism was associated with childhood symptoms of depression and anxiety in two independent samples of young children (Ns=476 and 409). In both samples, preschool-aged children were genotyped for the COMT val158met polymorphism. Symptoms of psychopathology were assessed via parent interviews and primary caregiver reports. In both samples, children homozygous for the val allele had higher levels of depressive symptoms compared to children with at least one copy of the met allele. Our findings extend previous research in older participants by showing links between the COMT val158met polymorphism and internalizing symptoms in early childhood. (c) 2013 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据